Evaluation of Antioxidative and Cytotoxic Activities of Streptomyces pluripotens MUSC 137 Isolated from Mangrove Soil in Malaysia by Hooi-Leng Ser et al.
ORIGINAL RESEARCH
published: 16 December 2015
doi: 10.3389/fmicb.2015.01398
Edited by:
Dongsheng Zhou,
Beijing Institute of Microbiology
and Epidemiology, China
Reviewed by:
Jyl Matson,
University of Toledo, USA
Lorenzo Giacani,
University of Washington, USA
*Correspondence:
Learn-Han Lee
lee.learn.han@monash.edu;
leelearnhan@yahoo.com;
Bey-Hing Goh
goh.bey.hing@monash.edu
Specialty section:
This article was submitted to
Microbial Physiology and Metabolism,
a section of the journal
Frontiers in Microbiology
Received: 06 October 2015
Accepted: 24 November 2015
Published: 16 December 2015
Citation:
Ser H-L, Ab Mutalib N-S, Yin W-F,
Chan K-G, Goh B-H and Lee L-H
(2015) Evaluation of Antioxidative
and Cytotoxic Activities
of Streptomyces pluripotens MUSC
137 Isolated from Mangrove Soil
in Malaysia. Front. Microbiol. 6:1398.
doi: 10.3389/fmicb.2015.01398
Evaluation of Antioxidative and
Cytotoxic Activities of Streptomyces
pluripotens MUSC 137 Isolated from
Mangrove Soil in Malaysia
Hooi-Leng Ser1, Nurul-Syakima Ab Mutalib2, Wai-Fong Yin3, Kok-Gan Chan3,
Bey-Hing Goh1* and Learn-Han Lee1*
1 Biomedical Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia,
Bandar Sunway, Malaysia, 2 UKM Medical Molecular Biology Institute–UKM Medical Centre, Universiti Kebangsaan
Malaysia, Kuala Lumpur, Malaysia, 3 Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of
Science, University of Malaya, Kuala Lumpur, Malaysia
Streptomyces pluripotens MUSC 137 was isolated from mangrove soil obtained
from Tanjung Lumpur, Pahang, Malaysia. We investigated the phylogenetic, genomic,
biochemical, and phenotypic characteristics of this strain. Uniquely adapted
microorganisms from mangrove habitats have previously yielded compounds of
biopharmaceutical interest. In order to examine the bioactivities possessed by the
strain, fermentation extract was prepared through solvent extraction method prior
to bioactivities screenings. Antioxidant activity was examined via DPPH assay while
the cytotoxic effect was assessed by means of examining the activity of the extract
against selected human cancer cell lines, namely colon cancer cells (HCT-116, Caco-
2, SW480, and HT-29), breast cancer cell (MCF-7), lung cancer cell (A549), prostate
cancer cell (DU145), and cervical cancer cell (Ca Ski). The results revealed MUSC
137 possesses significant antioxidant activity and demonstrates cytotoxic effect against
several cancer cell lines tested. The results indicated MCF-7 cells were most susceptible
to the extract with the lowest IC50 (61.33 ± 17.10 µg/mL), followed by HCT-116 and
A549. Additionally, selective index (SI) showed that MUSC 137 extract was less toxic
against normal cell lines when compared to MCF-7 and HCT-116 cells. The extract
was further subjected to chemical analysis using GC–MS and revealed the presence
of deferoxamine and pyrrolizidines related compounds which may account for the
antioxidant and cytotoxic properties observed.
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INTRODUCTION
Mangrove is a special woody plant area of intertidal coasts in tropical and subtropical coastal
regions. Mangrove ecosystems are habitats of various ﬂora and fauna of marine, freshwater, and
terrestrial species (Jennerjahn and Ittekkot, 2002). The constant changes in salinity and tidal
gradient in the mangrove ecosystem have become driving forces for metabolic pathway adaptations
that could direct to the production of useful metabolites (Hong et al., 2009; Lee et al., 2014a).
Therefore, the growing interest in the utilization of mangrove microorganism resources have
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indirectly led to the discovery of Streptomyces from the diﬀerent
mangrove environments globally, such as the isolation of
Streptomyces sanyensis (Sui et al., 2011), S. shenzhenensis (Hu
et al., 2011), S. qinglanensis (Hu et al., 2012), S. pluripotens (Lee
et al., 2014b), S. gilvigriseus (Ser et al., 2015a), and S. mangrovisoli
(Ser et al., 2015b).
The genus Streptomyces was proposed by Waksman and
Henrici (1943) and at the time of writing (July 2015), the
genus Streptomyces is comprised of ca. 600 species with validly
published names1. Over the years, through traditional cultivation
methods, many of the bioactive compounds have been isolated
from Streptomyces species, including antibacterial, antifungal,
antioxidant, and antitumor compounds (Hong et al., 2009; Qin
et al., 2011; Kawahara et al., 2012; Lee et al., 2014a,b; Kumar
et al., 2014; Tan et al., 2015). The importance of these organisms
is clearly seen from the fact that approximately 70% of the
antibiotics in use were derived from actinobacteria (Subramani
and Aalbersberg, 2012), of which 75% were derived from genus
Streptomyces (Berdy, 2005; Rehm et al., 2009; Crnovcic et al.,
2013).
In our screening program to explore the potential biological
activity possessed by the strain MUSC 137, the extract was
prepared and the free radical scavenging assay was used to
evaluate the antioxidant activity. Diﬀerent type of human cancer
cell lines derived from colon, breast, cervical, prostate, and
lung were selected for the screening of cytotoxic activity. These
results indicated that MUSC 137 extract exhibited a signiﬁcant
antioxidant and cytotoxic properties. The extract was then
subjected to chemical analysis with the use of GC–MS, which
eventually led to the identiﬁcation of chemical constituents
present in the extract of MUSC 137. Taken all together, the
well characterized strain, S. pluripotens MUSC 137 isolated from
mangrove soil in Tanjung Lumpur could be a potential good
source of antioxidative and chemopreventive agents.
MATERIALS AND METHODS
Sample Collection and Isolation of Strain
Streptomyces pluripotens MUSC 137
Strain MUSC 137 was isolated from a soil sample collected in
December 2012 from site MUSC-TLS4 (3◦ 48′ 21.3′′ N 103◦
20′ 3.3′′ E) located in the Tanjung Lumpur mangrove forest in
the state of Pahang, Peninsular Malaysia. Topsoil samples of the
upper 20-cm layer (after removing the top 2–3 cm) were collected
and sampled into sterile plastic bags using an asepticmetal trowel,
and stored at –20◦C. Air-dried soil samples were ground with
a mortar and pestle. Selective pretreatment of soil samples was
performed using wet heat in sterilized water (15 min at 50◦C;
Takahashi et al., 1996). Five grams of the pretreated air-dried
soil was mixed with 45 ml sterilized water and mill ground,
spread onto the isolation medium ISP 2 (Shirling and Gottlieb,
1966) supplemented with cycloheximide (25 µg/ml) and nystatin
(10 µg/ml), and incubated at 28◦C for 14 days. Pure cultures of
1http://www.bacterio.cict.fr/
strain MUSC 137 were maintained on slants of ISP 2 agar at 28◦C
and as glycerol suspensions (20%, v/v) at –20◦C.
Genomic and Phylogenetic
Characterization
The bioactive-producing strain S. pluripotens MUSC 137 was
characterized based on phylogenetic, genomic, biochemical, and
phenotypic approaches. The extraction of genomic DNA and
PCR was performed as described by Hong et al. (2009). The
ampliﬁcation of 16S rRNA gene was performed according to
Lee et al. (2014b). The 16S rRNA gene sequence of strain
MUSC 137 was aligned with representative sequences of related
type strains of the genus Streptomyces retrieved from the
GenBank/EMBL/DDBJ databases using CLUSTAL-X software
(Thompson et al., 1997). The alignment was veriﬁed manually
and adjusted prior to the reconstruction of phylogenetic
trees. Phylogenetic trees were constructed with the maximum-
likelihood algorithm (Felsenstein, 1981), (Figure 1) using MEGA
version 6.0 (Tamura et al., 2013). The EzTaxon-e server2 (Kim
et al., 2012) was used for calculation of sequence similarity.
The stability of the resultant trees topologies were evaluated by
using the bootstrap resampling method of Felsenstein (1985).
The BOX-PCRﬁngerprint analysis was used to characterize strain
MUSC 137 and the closely related strains using the primer
BOX-A1R (5′-CTACGGCAAGGCGACGCTGACG-3′; Lee et al.,
2014c). The PCR condition for BOX-PCR was performed as
described by Lee et al. (2014d). The PCR products were visualized
by 2% agarose gel electrophoresis.
The genomic DNA extraction for DNA-DNA hybridization of
strain MUSC 137 with S. pluripotens MUSC135T was performed
according to protocol of Cashion et al. (1977). The DNA–DNA
hybridization was carried out by the Identiﬁcation Service of the
DSMZ, Braunschweig, Germany following the protocol of De Ley
et al. (1970) under consideration of the modiﬁcations described
by Huss et al. (1983).
Phenotypic Characterization
The cultural characteristics of strain MUSC 137 were determined
following growth on ISP2 and ISP7 agar (Shirling and Gottlieb,
1966), starch casein agar (SCA; Küster and Williams, 1964),
Streptomyces agar (SA; Atlas, 1993), Actinomycetes isolation
agar (AIA; Atlas, 1993), and nutrient agar (Macfaddin, 2000)
for 7–14 days at 28◦C. Light microscopy (80i, Nikon) and
scanning electron microscopy (JEOL-JSM 6400) were used to
observe the morphology of the strain after incubation on ISP2
agar at 28◦C for 7–14 days (Figure 2). The designation of
colony color was determined by using the ISCC-NBS color
charts (Kelly, 1964). Gram staining was performed by standard
Gram reaction and conﬁrmed by using KOH lysis (Cerny, 1978).
The NaCl tolerance [0–10% (w/v)] and pH range (pH 4.0–
10.0) for growth was tested in TSB. The growth temperature
range was tested at 4–40◦C at intervals of 4◦C on ISP2 agar.
The responses to temperature, pH and NaCl were observed
for 14 days. Hemolytic activity was assessed on blood agar
medium containing 5% (w/v) peptone, 3% (w/v) yeast extract,
2http://eztaxon-e.ezbiocloud.net/
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FIGURE 1 | Maximum-likelihood phylogenetic tree based on almost complete 16S rRNA sequences (1491 nucleotides) showing the relationship
between strain MUSC 137 and representatives of some other related taxa. Numbers at nodes indicate percentages of 1000 bootstrap re-samplings, only
values above 50% are shown. Bar, 0.002 substitutions per site.
5% (w/v) NaCl, and 5% (v/v) horse blood (Carrillo et al.,
1996). The plates were examined for hemolysis after incubation
at 28◦C for 7–14 days. Catalase activity and production
of melanoid pigments were determined following protocols
described by Lee et al. (2014e). Amylolytic, cellulase, chitinase,
lipase, protease, and xylanase activities were determined on
ISP2 agar as described by Meena et al. (2013). Antibiotic
susceptibility tests were performed by the disk diﬀusion method
as described by Shieh et al. (2003). Carbon-source utilization and
chemical sensitivity assays were determined using Biolog GenIII
MicroPlates (Biolog, USA) according to the manufacturer’s
instructions. Antimicrobials used and their concentrations are
as follows: ampicillin (10 µg), ampicillin sulbactam (30 µg),
cefotaxime (30 µg), cefuroxime (30 µg), cephalosporin (30 µg),
chloramphenicol (30 µg), ciproﬂoxacin (10 µg), erythromycin
(15 µg), gentamicin (20 µg), nalidixic acid (30 µg), Penicillin
G (10 µg), streptomycin (10 µg), tetracycline (30 µg), and
vancomycin (30 µg).
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FIGURE 2 | Scanning electron microscope of Streptomyces
pluripotensMUSC 137.
Extract Preparation of MUSC 137
Strain MUSC 137 was grown in seed medium (TSB) for 14 days
prior to fermentation. The fermentation medium, FM3 was
sterilized by autoclaving at 121◦C for 15 min prior to experiment
(Hong et al., 2009; Lee et al., 2014a). Fermentation was performed
in shaking 500 mL Erlenmeyer ﬂask containing 200 mL of
FM3, for 7–10 days at 28◦C. The resulting FM3 medium
was recovered by centrifugation at 12000 g for 15 min. The
supernatant was ﬁltered and subjected to freeze dry process. Once
freeze-dried, the sample was extracted thrice with methanol.
The extracting solvent was removed and concentrated by rotary
vacuum evaporator at 40◦C. The extract of MUSC 137 was
collected and suspended in dimethyl sulfoxide (DMSO) as vehicle
reagent prior to assay.
Investigation of Antioxidant Activity of
MUSC 137 Extract Using
2,2-Diphenyl-1-Picrylhydrazyl (DPPH)
Radical Scavenging Method
Antioxidant activity of MUSC 137 extract was examined by
measuring radical scavenging ability using DPPH (Sigma–
Aldrich). Scavenging activity on DPPH free radicals was
determined using previous protocol with minor modiﬁcations
(Ling et al., 2009). Reduction in the amount of free radicals
present was measured via a decrease in absorbance of 515 nm.
Volume of 195µL of 0.016%DPPH ethanolic solution was added
to 5µL of extract solution to make up ﬁnal volume of 200µL. For
control, DMSO was added in place of extract, while gallic acid
was included as positive control. Reactions were carried out in
the dark at room temperature for 20 min before measurement
with spectrophotometer at 515 nm. DPPH scavenging activity
was calculated as follows:
DPPH scavenging activity =
Absorbance of control − Absorbance of sample
Absorbance of control
× 100%
Determination of Cytotoxicity Activity of
MUSC 137 Using
3-(4,5-Dimethylthazol-2yl)-2,5-Diphenyl
Tetrazolium-Bromide (MTT) Assay
For evaluation of cytotoxicity, a variety of human derived cancer
cell lines were selected for testing: (a) colon cancer cell, HCT-
116, HT-29, Caco-2 and SW480; (b) breast cancer cell, MCF-7;
(c) cervical cancer cell, Ca Ski; (d) lung carcinoma cell line,
A549; (e) prostate cancer cell, DU 145. Cells were grown in
RPMi 1640 supplemented with 10% FBS in humidiﬁed incubator
(5% CO2 in air at 37◦C). Cells were seeded into a sterile ﬂat
bottom 96-well plate at a density of 5× 103 cells/well and allowed
to adhere overnight. MUSC 137 extract was added to the cells
(0–400 µg/mL) and further incubated for 72 h before performing
MTT assay. Curcumin (1.56–25 µg/mL) was included as positive
control. Twenty microliter of 5 mg/mL of MTT (Sigma) was
then added to each well and the plates were incubated at 37◦C
in a humid atmosphere with 5% CO2, 95% air for 4 h. The
medium was then gently aspirated, and 100 µL of DMSO was
added to dissolve the formazan crystals. The amount of formazan
product was determined spectrophotometrically at 570 nm (with
650 nm as reference wavelength) using a microplate reader. The
percentage of cell viability was calculated with follows:
Percentage of cell viability =
Absorbance of treated cells
Absorbance of untreated cells
× 100%
The 50% inhibitory concentration of extract (IC50) was derived
from the plotted graphs for each cell line. VERO cells were used
as a normal cell model for determination of selective index (SI).
SI value was calculated by dividing IC50 of cancer cell line with
IC50 value of normal cell line.
Gas Chromatography–Mass
Spectrometry (GC–MS) Analysis
Gas chromatography–mass spectrometry analysis was performed
as previously described (Ser et al., 2015b). The equipment used
was Agilent Technologies 6980N (GC) equipped with 5979 Mass
Selective Detector (MS), HP-5MS (5% phenyl methyl siloxane)
capillary column of dimensions 30.0 m× 250µm× 0.25µm and
used helium as carrier gas at 1 mL/min. The column temperature
was programmed initially at 40◦C for 10 min, followed by an
increase of 3◦C/min to 250◦C and was kept isothermally for
5 min. The MS was operating at 70 eV. The constituents were
identiﬁed by comparison of their mass spectral data with those
from NIST 05 Spectral Library.
Statistical Analysis
Experiments to investigate antioxidant and cytotoxic activities
were done in quadruplicate. Data analysis was performed with
SPSS statistical analysis software and the results were expressed
as mean ± standard deviation (SD). One-way analysis of
variance (ANOVA) was used for comparison of more than two
means. A diﬀerence was considered statistically signiﬁcant when
p ≤ 0.05.
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RESULTS
Phenotypic Analyses of Strain S.
pluripotens MUSC 137
Strain MUSC 137 was Gram-positive and aerobic. The strain
grew well on ISP2 medium, SA and SCA after 1–2 weeks
at 28◦C, it grew moderately on Luria Bertani agar, ISP7
medium and nutrient agar, whereas it grew poorly on AIA. The
morphological observation of the 15-day-old culture grown
on ISP2 medium showed a smooth spore surface, with aerial
and vegetative hyphae which was well developed and not
fragmented. These morphological characteristics were consistent
with its assignment to the genus Streptomyces (Williams
et al., 1989), (Figure 2). The colors of the aerial and substrate
mycelium were yellowish gray and brilliant yellow. Growth
occurred at pH 5.0–9.0 (optimum pH 5.0–8.0), with 0–6%
NaCl tolerance (optimum 0–4%) and at 24–40◦C (optimum
28–32◦C). MUSC 137 was positive for catalase but negative
for hemolytic activity and melanoid pigment production.
Hydrolysis of soluble starch and carboxymethylcellulose were
positive; but negative for hydrolysis of tributyrin (lipase),
casein, chitin, and xylan. Strain MUSC 137 was found to
be able to utilize various compounds as carbon sources
(Supplementary Table S1). The strain was sensitive to ampicillin,
ampicillin sulbactam, cefotaxime, cefuroxime, cephalosporin,
chloramphenicol, ciproﬂoxacin, erythromycin, gentamicin,
nalidixic acid, Penicillin G, streptomycin, tetracycline, and
vancomycin.
Phylogenetic and Genomic Analyses
The almost-complete 16S rRNA gene sequences were determined
for strain MUSC 137 (1491 bp) and aligned manually with the
corresponding partial 16S rRNA gene sequences of the type
strains of representative members of the genus Streptomyces
retrieved from GenBank/EMBL/DDBJ databases. A phylogenetic
tree constructed based on the 16S prRNA gene sequences showed
that strain MUSC 137 (Figure 1) formed a distinct clade with
type strains S. pluripotens MUSC 135T, S. mexicanus NBRC
100915T, S. cinereospinusNBRC 15397T, S. coeruleofuscus NBRC
12757T, and S. chromofuscus NBRC 12851T. Strain MUSC 137
and S. pluripotens MUSC 135T formed a distinct subclade
at 100% bootstrap value, indicating the high conﬁdence level
of the association (Figure 1). Strain MUSC 137 exhibited
highest 16S rRNA gene sequence similarity to S. pluripotens
MUSC 135T (100%), followed by S. cinereospinus NBRC 15397T
(99.18%), which corresponds to 12 nucleotide diﬀerences at 1462
locations with gaps, and lower similarity values to S. mexicanus
NBRC 100915T (99.17%) and S. coeruleofuscus NBRC 12757T
(98.97%).
The DNA–DNA relatedness values between strain MUSC
137 and S. pluripotens MUSC 135T were 83 ± 3.2%, which
were signiﬁcantly higher that 70%, the threshold value for the
delineation of bacterial species (Wayne et al., 1987). These results
supported the notion that strain MUSC 137 belonged to the
same species as S. pluripotensMUSC 135T. The BOX-PCR results
exhibited that strain MUSC 137 presented a unique BOX-PCR
ﬁngerprint as compared to MUSC 135T and other closely related
type strains (Supplementary Figure S1).
Antioxidant and Cytotoxic Activity of
MUSC 137 Extract
The results obtained from DPPH free radical scavenging assay
showed signiﬁcant antioxidant activity of MUSC 137 extract
with 35.03 ± 3.74% scavenging activity at 2 mg/mL (Table 1).
In addition, the extract of MUSC 137 displayed variable levels
of cytotoxic activity against all the tested human cancer cell
lines, with our work recording viability of tested cells ranging
from 18.5 to 76.2% (Figure 3). A dose response pattern was
evaluated using diﬀerent doses which indicated that the extract
may be eﬀective against some cancer cell lines even at the
lowest tested concentration (25 µg/mL). The lowest IC50 value
of MUSC 137 extract was recorded at 61.33 ± 17.10 µg/mL for
MCF-7 cells, followed by HCT-116 (83.72 ± 7.17 µg/mL), A549
(147.20 ± 19.23 µg/mL) as shown in Table 2. Higher IC50 values
of MUSC 137 extract were observed for Ca Ski and HT-29, at
300.50 ± 19.76 µg/mL and 300.98 ± 27.52 µg/mL, respectively.
Of particular note, the extract showed higher level of
cytotoxicity against some cancer cell lines with low cytotoxic
eﬀects in normal cell lines. The calculation of selectivity index (SI)
allows comparison of cytotoxicity by dividing IC50 value of each
cancer cell lines and IC50 value of normal cell line. The extract
was less cytotoxic to normal cells as indicated by the SI value of
4.22 when compared to MCF-7 cells, followed by HCT-116 with
value of 3.09 (Table 3).
GC–MS Analysis of MUSC 137 Extract
Gas chromatography–mass spectrometry analysis identiﬁed nine
compounds present in the methanolic extract of MUSC
137 (Table 4) and the chemical structures (Figure 4)
as 2,2-dimethoxybutane (1), Benzeneacetamide (2),
Phenol, 2,5-bis(1,1-dimethylethyl)- (3), (3R,8aS)-3-methyl-1,2,3,
4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine-1,4-dione (4), 2,5-
cyclohexadiene-1,4-dione (5), Pyrrolo[1,2-a]pyrazine-1,4-
dione, hexahydro- (6), 1,4-diaza-2,5-dioxo-3-isobutyl bicyclo
[4.3.0]nonane (7), Deferoxamine (8), Pyrrolo[1,2-a]pyrazine-
1,4-dione, hexahydro-3-(2-phenylmethyl)- (9).
DISCUSSION
Microorganisms have served as a promising source for the
majority of the drugs in use today (Berdy, 2005; Azman et al.,
TABLE 1 | DPPH free radical scavenging assay showing antioxidant
activity of MUSC 137 extract.
Sample Concentration (µg/mL) Scavenging activity (%)
MUSC 137 extract 250 1.01 ± 1.30
500 13.41 ± 3.60
1000 23.24 ± 5.00
2000 35.03 ± 3.74
Gallic acid 6.25 47.11 ± 4.15
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FIGURE 3 | Cytotoxic activity of MUSC 137 extract against human cancer cell lines. Cell viability was measured using MTT assay. The graphs show
cytotoxicity effects of MUSC 137 extract against (A) HCT-116, (B) HT-29, (C) Caco-2, (D) SW480, (E) MCF-7, (F) Ca Ski, (G) A549, (H) DU 145. ∗ indicates
significant difference when compared with control (p value < 0.05).
2015). Their ability to produce a diverse array of bioactive
small molecule natural products has made them among the
key players in the search for novel therapeutic or preventive
agents against diseases including cancer, neurodegenerative
diseases and diabetes (Berdy, 2005; Chin et al., 2006). The
phylum Actinobacteria produces approximately 10,000 clinically
important compounds, of which about 75% are isolated from
the genus Streptomyces (Watve et al., 2001; Berdy, 2005).
These ﬁlamentous bacteria under the genus Streptomyces
are economically important from a biotechnological and
pharmacological point of view as they seem to be a virtually
inexhaustible source of bioactive secondary metabolites with
potent antibacterial, antifungal, antitumor and antioxidant
activity (Kim et al., 2008; Olano et al., 2009a; Saurav and
Kannabiran, 2012; Wang et al., 2013). In the current study,
S. pluripotens MUSC 137 was isolated from a soil sample from
a mangrove forest in Pahang, Peninsular Malaysia. Results from
phylogenetic and genomic analyses indicated that strain MUSC
137 is closely related to S. pluripotensMUSC 135T as they formed
a distinct subclade at 100% bootstrap value. Furthermore, the
DNA–DNA relatedness values between MUSC 137 and MUSC
135T were 83 ± 3.2%, which were signiﬁcantly higher that
70%, the threshold value for the delineation of bacterial species
(Wayne et al., 1987). Also the BOX-PCR results exhibited that
strain MUSC 137 presented a unique BOX-PCR ﬁngerprint as
compared to MUSC 135T and other closely related type strains,
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TABLE 2 | IC50 value of MUSC 137 extract against several human cancer
cell lines.
Cell lines IC50 value (µg/mL)
MUSC 137 extract Curcumin
MCF-7 61.33 ± 17.10 6.09 ± 0.59
HCT-116 83.72 ± 7.17 2.63 ± 0.26
A549 147.20 ± 19.23 6.65 ± 0.25
Ca Ski 300.50 ± 19.76 1.85 ± 0.83
HT-29 300.98 ± 27.52 4.60 ± 0.28
DU 145 >400 8.76 ± 1.48
SW480 >400 6.81 ± 0.19
Caco-2 >400 7.23 ± 0.36
IC50 value represents concentration that reduces cell viability to 50%.
TABLE 3 | Selectivity index (SI) of MUSC 137 extract.
Cell lines Selectivity index
MCF-7 4.22
HCT-116 3.09
A549 1.76
Ca Ski 0.86
HT-29 0.86
DU 145 N.A.
SW480 N.A.
Caco-2 N.A.
N.A., not available. SI values were determined by dividing IC50 value of VERO cells
with IC50 value of each cancer cell lines.
indicating that MUSC 137 and MUSC 135T are not clones.
Overall, these results support the notion that strain MUSC 137
belonged to the same species as S. pluripotens MUSC 135T but
has suﬃcient unique characteristics to be designated as a separate
strain.
Cancer initiation and progression is associated with
accumulation of free radicals or oxidative stress (Reuter
et al., 2010). In general, free radicals cause various modiﬁcations
or cause damage to biological macromolecules such as proteins,
lipids and DNA. These deleterious eﬀects then compromise
functioning of important pathways including the DNA repair
system which eventually results in an increased mutation
rate (Paciﬁci and Davies, 1991; Bartsch and Nair, 2006).
As antioxidants are capable of scavenging free radicals,
these molecules could potentially aﬀect the activation of
signaling pathways which are crucial for survival of cancer
cells (Lopaczynski and Zeisel, 2001; Chen et al., 2009). The
bioactive potential of S. pluripotens strain MUSC 137 was
explored using DPPH free radical scavenging assay to determine
antioxidant activity. In the presence of antioxidants, the
odd electron of DPPH radical is paired oﬀ which causes
discoloration of the solution. This important characteristic
has enabled researchers to assess the antioxidant strength
of the sample(s) of interest. In this current study, DPPH
assay revealed signiﬁcant antioxidant activity of MUSC 137
extract (Table 1), which suggests that the strain may produce
valuable compound(s) that could potentially reduce cancer
occurrence and be further developed as chemopreventive
drugs.
The cytotoxicity of MUSC 137 extract against several human
cancer cell lines was examined withMTT assay. This tetrazolium-
based colorimetric assay measures only in vitro living cells
and is often employed in cytotoxicity studies to evaluate drug
eﬃciency (Rubinstein et al., 1990; Ciapetti et al., 1993; Fotakis
and Timbrell, 2006; Chan et al., 2015). The extract of MUSC 137
displayed varying levels of cytotoxicity against the tested cancer
cell lines. MCF-7 was found to be the most vulnerable to the
treatment extract with the lowest IC50 (61.33 ± 17.10 µg/mL),
followed by HCT-116 (83.72 ± 7.17 µg/mL) and A549
(147.20 ± 19.23 µg/mL). Among the tested colon cancer cell
lines, the treatment of MUSC 137 extract at the highest tested
concentration (400 µg/mL) showed strongest growth inhibition
against HCT-116 (18.5 ± 7.8%), while higher percentages of
cell viability were still observed in HT-29 (44.1 ± 2.9%), Caco-
2 (50.8 ± 2.1%), and SW480 (56.4 ± 1.3%). The tested colon
cancer cell lines are known to possess dysfunctional p53 tumor
protein, except HCT-116. Therefore, the varied levels of cytotoxic
activity among these colon cancer cell lines exhibited by extract
of MUSC 137 might be due to the p53 tumor suppressor protein
status of these cancer cell lines (Petitjean et al., 2007; Goh
et al., 2014). These ﬁndings have led to the speculation that
MUSC 137 extract might be able to induce cancer cell death via
p53 dependent cell death signaling pathway. Elucidation of the
underlying mechanism of MUSC 137 extract on cancer cell lines
may be a valuable area of future research as these information
could potentially assist in its development as chemopreventive
drug.
An ideal chemotherapy drug should have high speciﬁcity
and should be able to discriminate between cancer and
normal cells. However, many of the anticancer drugs in use
are still lacking in the drug speciﬁcity as they kill both
cancer cells as well as normal cells (Chabner and Roberts,
2005; Chari, 2007; Fernandez, 2014). Tremendous eﬀorts have
been invested to search for novel chemotherapy drugs with
high potency and speciﬁcity. This current study investigating
speciﬁcity of MUSC 137 extract revealed that the extract
was less toxic against normal cell lines when compared to
MCF-7 and HCT-116 cancer cell lines as shown by the SI
value of 4.22 and 3.09, respectively. These crucial ﬁndings
have provided new insight into the cytotoxic potential of
MUSC 137 against cancer cells, particularly against MCF-7 and
HCT-116 with high speciﬁcity. Further analysis investigating
the target action of the bioactive compounds could provide
helpful information for future development as an anticancer
drug. In summary, the results of both the DPPH assay and
in vitro anticancer screening suggests the presence of potent
biologically active compounds in the extract of MUSC 137,
which then prompted subsequent chemical analysis using
GC–MS to identify the chemical constituents present in the
extract.
A powerful analytical tool, GC–MS combines the separation
power of GC and detection power of MS, generating robust
and reliable data (Hites, 1997; Stein, 1999). GC–MS plays an
important role in natural product discovery, including bioactive
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TABLE 4 | Compounds identified from MUSC 137 extract through GC–MS.
No Retention time (min) Compound Formula Molecular weight
(MW)
Quality (%)
1 4.781 2,2-dimethoxybutane C6H14O2 118 83
2 39.358 Benzeneacetamide C8H9NO 135 90
3 44.457 Phenol, 2,5-bis(1,1-dimethylethyl)- C14H22O 206 90
4 51.540 (3R,8aS)-3-methyl-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine-1,4-dione C8H12N2O2 168 86
5 51.878 2,5-cyclohexadiene-1,4-dione C6H4O4 140 56
6 53.028 Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro- C7H10N2O2 154 97
7 58.476 1,4-diaza-2,5-dioxo-3-isobutyl bicyclo[4.3.0]nonane C11H18N2O2 210 72
8 71.556 Deferoxamine C25H48N6O8 560 81
9 72.054 Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-phenylmethyl)- C14H16N2O2 244 58
FIGURE 4 | Chemical structures of the identified compounds from
MUSC 137. (1), 2,2-dimethoxybutane; (2), Benzeneacetamide; (3),
Phenol, 2,5-bis(1,1-dimethylethyl)-; (4), (3R,8aS)-3-methyl-1,2,3,4,6,7,8,8a-
octahydropyrrolo[1,2-a]pyrazine-1,4-dione; (5), 2,5-cyclohexadiene-1,
4-dione; (6), Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-; (7),
1,4-diaza-2,5-dioxo-3-isobutyl bicyclo[4.3.0]nonane; (8), Deferoxamine; (9),
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-phenylmethyl)-.
compounds derived from Streptomyces species (Pollak and
Berger, 1996; Sudha and Masilamani, 2012; Ara et al., 2014;
Jog et al., 2014). In the current study, GC–MS detected nine
compounds in the extract of MUSC 137, with the majority
of the compounds having been detected in marine-derived
microorganisms including Streptomyces species (Hong et al.,
2008; Gao et al., 2014; Narendhran et al., 2014). The analysis
detected several members of pyrrolizidines which are known to
exhibit a diverse array of bioactivities including antimicrobial,
antitumor, anti-angiogenesis and antioxidant activities (Olano
et al., 2009b; Melo et al., 2014; Robertson and Stevens, 2014).
The pyrrolizidines in the extract of MUSC 137 include 1,4-diaza-
2,5-dioxo-3-isobutyl bicyclo[4.3.0]nonane, Pyrrolo[1,2-a]
pyrazine-1,4-dione, hexahydro-3-(2-phenylmethyl)-, Pyrrolo[1,
2-a]pyrazine-1,4-dione, hexahydro- and (3R,8aS)-3-methyl-1,
2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine-1,4-dione. As a
matter of fact, Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-
3-(2-phenylmethyl)- has been shown to inhibit expression of
serine/threonine kinase Akt which involves in regulation cell
proliferation and apoptosis (Hong et al., 2008). Furthermore,
the chemical compound 1,4-diaza-2,5-dioxo-3-isobutyl bicyclo
[4.3.0]nonane has also been associated with the cytotoxic activity
observed on human cervical cancer cell line (Narendhran et al.,
2014). Therefore, the presence of these compounds in the extract
of MUSC 137 could account for the observed cytotoxicity against
the tested cancer cell lines.
In addition, GC–MS analysis also detected compounds
that may account for the antioxidant activity observed. In the
current study, Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-
and (3R,8aS)-3-methyl-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-
a]pyrazine-1,4-dione were also found in other Streptomyces
and Bacillus strains which exhibited antioxidant activity (Gopi
et al., 2014; Ser et al., 2015b). As antioxidants are suggested to
aﬀect survival of cancer cells (Lopaczynski and Zeisel, 2001;
Chen et al., 2009), these pyrrolizidines with antioxidant activity
in MUSC 137 could be contributing to the observed cytotoxic
eﬀects. Besides pyrrolizidines, GC–MS has also revealed the
presence of deferoxamine in MUSC 137. Deferoxamine (with
the prescription name of Desferal) is listed on World Health
Organization’s List of Essential Medicines due to its medical
importance as iron chelator and to protect against iron-induced
oxidative stress (World Health Organization [WHO], 2015).
This trihydroxamate molecule can reduce accumulation of free
radicals and inhibit growth of various cancer cell lines and
tumors (Tomoyasu et al., 1992; Shimoni et al., 1994; Melillo et al.,
1997; Buss et al., 2004; Yamasaki et al., 2011; Salis et al., 2014).
The detection of deferoxamine in MUSC 137 might be associated
with the antioxidant activity. Also, it may aﬀect the expression of
crucial genes and signaling pathways responsible for the survival
of cancer cells, subsequently leading to a reduction in viability of
cancer cell as shown in MTT assay.
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CONCLUSION
This study has revealed the biopharmaceutical potential
possessed by S. pluripotens strain MUSC 137 as this
strain has demonstrated its ability to produce bioactive
compounds which may account for its antioxidant and
cytotoxic activities. Future studies should focus on the
elucidation of mechanism action of cell death to provide more
convincing evidence of selective cytotoxic activity observed
and work investigating this phenomenon is in fact currently
underway.
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